Ellipsys Vascular Access System Post Market Surveillance (PS) Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Haimanot Wasse, MD
Rush University Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Nephrology Associates Access Center
Riverside, California, United States
- Yale University
New Haven, Connecticut, United States
- Azura Vascular Care, Jacksonville
Jacksonville, Florida, United States
- Coastal Vascular and Interventional, Pllc
Pensacola, Florida, United States
- Rush University Medical Center
Chicago, Illinois, United States
- the Vascular Care Group
Hyannis, Massachusetts, United States
- Nephrology Kidney Disease Hypertension Center
Las Vegas, Nevada, United States
- Staten Island Hospital
Staten Island, New York, United States
- University of Pittsburg Medical Center
Pittsburgh, Pennsylvania, United States
- Star Vascular Access Center
San Antonio, Texas, United States
- San Antonio Kidney Disease Center
San Antonio, Texas, United States
- Richmond Vascular Center
North Chesterfield, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Apr 2021
- Primary completion
- 31 Mar 2025
- Completion
- 31 Mar 2025
- Last update posted
- 1 Jun 2026
- Registered enrollment
- 142
- Registry id
- NCT04484220
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.